Tunneled Dialysis Catheter Insertion in External Jugular Vein by Nephrologists

Pub Date : 2024-07-08 DOI:10.25259/ijn_511_23
Vineet Behera, Shahbaj Ahmad, Smriti Sinha, Gireesh Reddy G, K. Srikanth, Indranil Ghosh, P. Chauhan, Ananthakrishnan Ramamoorthy, Vivek Hande
{"title":"Tunneled Dialysis Catheter Insertion in External Jugular Vein by Nephrologists","authors":"Vineet Behera, Shahbaj Ahmad, Smriti Sinha, Gireesh Reddy G, K. Srikanth, Indranil Ghosh, P. Chauhan, Ananthakrishnan Ramamoorthy, Vivek Hande","doi":"10.25259/ijn_511_23","DOIUrl":null,"url":null,"abstract":"\n\nExternal jugular vein (EJV) is used to insert tunneled dialysis catheter (TDC) in patients with no AVF and exhausted right internal jugular veins (IJV). There is scarce data on TDC insertion in EJV by nephrologists with fluoroscopy guidance.\n\n\n\nThis was a prospective observational study that included hemodialysis patients with exhausted right IJV access who underwent EJV TDC insertion, and excluded occluded ipsilateral brachiocephalic vein or superior vena cava, EJV < 5 mm diameter, or patients with existing EJV TDC. All patients underwent evaluation of central veins. TDC insertions were performed by a nephrologist using ultrasound and fluoroscopic guidance. The primary outcome was the successful insertion of EJV TDC and catheter removal within 6 months due to major catheter dysfunction or complications.\n\n\n\nEJV TDC was successfully inserted in 23/23 cases (100% success), of which 17 (73.9%) were in right side, and 21 (91.3%) were denovo insertions. Catheter dysfunction needing removal occurred in seven cases (30.4%) with subclavian vein thrombosis in five cases (21.7%) and infectious complications in two cases (8.6%). The censored catheter survival was 23/23 (100%) at 1 month, 22/23 (95.6%) at 3 months, and 13/20 (65%) at 6 months. Cases of EJV catheter removal had a significant association with drainage of EJV into subclavian vein as compared to other anatomical variants (p = 0.005).\n\n\n\nEJV TDC insertion has a good technical success rate when performed under fluoroscopy. It is associated with an acceptable rate of catheter dysfunction, especially thrombosis, which is more common in EJV opening into subclavian veins.\n","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/ijn_511_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

External jugular vein (EJV) is used to insert tunneled dialysis catheter (TDC) in patients with no AVF and exhausted right internal jugular veins (IJV). There is scarce data on TDC insertion in EJV by nephrologists with fluoroscopy guidance. This was a prospective observational study that included hemodialysis patients with exhausted right IJV access who underwent EJV TDC insertion, and excluded occluded ipsilateral brachiocephalic vein or superior vena cava, EJV < 5 mm diameter, or patients with existing EJV TDC. All patients underwent evaluation of central veins. TDC insertions were performed by a nephrologist using ultrasound and fluoroscopic guidance. The primary outcome was the successful insertion of EJV TDC and catheter removal within 6 months due to major catheter dysfunction or complications. EJV TDC was successfully inserted in 23/23 cases (100% success), of which 17 (73.9%) were in right side, and 21 (91.3%) were denovo insertions. Catheter dysfunction needing removal occurred in seven cases (30.4%) with subclavian vein thrombosis in five cases (21.7%) and infectious complications in two cases (8.6%). The censored catheter survival was 23/23 (100%) at 1 month, 22/23 (95.6%) at 3 months, and 13/20 (65%) at 6 months. Cases of EJV catheter removal had a significant association with drainage of EJV into subclavian vein as compared to other anatomical variants (p = 0.005). EJV TDC insertion has a good technical success rate when performed under fluoroscopy. It is associated with an acceptable rate of catheter dysfunction, especially thrombosis, which is more common in EJV opening into subclavian veins.
分享
查看原文
肾脏科医生在颈外静脉插入隧道式透析导管
颈外静脉(EJV)用于为无动静脉瘘和右颈内静脉(IJV)通路衰竭的患者插入隧道式透析导管(TDC)。这是一项前瞻性观察研究,研究对象包括右侧颈内静脉通路衰竭且接受 EJV TDC 插入的血液透析患者,排除了同侧臂丛静脉或上腔静脉闭塞、EJV 直径小于 5 毫米或已有 EJV TDC 的患者。所有患者都接受了中心静脉评估。TDC插入由肾病专家在超声和透视引导下进行。23/23 例患者成功插入了 EJV TDC(100% 成功),其中 17 例(73.9%)位于右侧,21 例(91.3%)为重新插入。7例(30.4%)导管功能障碍,需要移除导管,其中5例(21.7%)发生锁骨下静脉血栓,2例(8.6%)发生感染并发症。经删减的导管存活率为:1 个月 23/23 例(100%),3 个月 22/23 例(95.6%),6 个月 13/20 例(65%)。与其他解剖变异相比,拔除 EJV 导管的病例与 EJV 引流至锁骨下静脉有显著关联(p = 0.005)。在透视下进行 EJV TDC 插入时,技术成功率较高,但导管功能障碍的发生率可接受,尤其是血栓形成,这在 EJV 开入锁骨下静脉时更为常见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信